scholarly journals All-Trans Retinoic Acid Modulates The Immune Status of M2 Macrophages in Experimental Periodontitis Induced by Porphyromonas Gingivalis in Mice

Author(s):  
Wenjuan Zhang ◽  
Ning Guan ◽  
Xiu-qiu Gao ◽  
Lin-yuan Wang

Abstract Background: M2 macrophages are important innate immune cells that participate in the pathogenesis of periodontitis. The effect of all-trans retinoic acid (ATRA) on the immune status of M2 macrophages in periodontitis has not been reported.Methods: An experimental model of periodontitis was established in mice by oral administration of Porphyromonas gingivalis, and then ATRA or vehicle was administered orally to model mice every other day (P.g+ATRA and P.g+CMC mice, respectively). Flow cytometry was used to analyze the numbers of F4/80+CD206+ M2 macrophages in the gingiva, spleen, and peritoneal lavage fluid (PLF). M2 macrophage–related cytokines were quantified by real-time reverse transcription-polymerase chain reaction.Results: Compared with P.g+CMC mice, P.g+ATRA mice showed a significantly reduced cemento-enamel junction to alveolar bone crest (CEJ-ABC) distance. The percentage of F4/80+CD206+ M2 macrophages in gingiva, PLF and spleen in model mice increased after ATRA treatment. The mRNA expression levels of M2 macrophage­–related cytokines (IL-10, TGF-b1 and Arg-1) in gingiva, PLF and spleen of P.g+ATRA mice were higher than those of P.g+CMC mice.Conclusions: These results suggested that ATRA modulates the immune status of M2 macrophages and provides protection against periodontitis by enhancing M2 activation.

Blood ◽  
2002 ◽  
Vol 99 (11) ◽  
pp. 4222-4224 ◽  
Author(s):  
Elihu H. Estey ◽  
Francis J. Giles ◽  
Miloslav Beran ◽  
Susan O'Brien ◽  
Sherry A. Pierce ◽  
...  

We administered gemtuzumab ozogamycin (“mylotarg”; 9 mg/m2 day 1 or 5) and all-trans retinoic acid (ATRA) to 19 patients with untreated acute promyelocytic leukemia (APL). There were 3 patients who also received idarubicin because of a white blood cell (WBC) count of more than 30 000/μL. In complete remission (CR), patients were to receive 8 courses of mylotarg (9 mg/m2 every 4 to 5 weeks) and ATRA; idarubicin was added only for persistent or recurrent polymerase chain reaction (PCR) positivity. The CR rate was 16/19 (84%). All 12 patients tested to date were PCR-negative 2 to 4 months from CR date; none of the 7 patients evaluated subsequently have reverted to PCR positivity (median follow-up in CR was 5 months, up to 14 months). Mylotarg was well tolerated. A median of 5 post-CR courses have been given to date with 3 patients having currently received 8 post-CR courses, and 4 patients receiving 7 post-CR courses. Mylotarg appears active in APL, and repeated administration is feasible.


2008 ◽  
Vol 45 (5) ◽  
pp. 545-551 ◽  
Author(s):  
Motone Kuriyama ◽  
Akikazu Udagawa ◽  
Shinya Yoshimoto ◽  
Masaharu Ichinose ◽  
Koji Sato ◽  
...  

Objectives: The aim of this study was to analyze epigenetic (specifically, DNA methylation) participation in the mechanisms of cleft palate only induced by maternal exposure to all-trans retinoic acid in mice. Design: Cleft palate only was induced in fetuses by maternal exposure to all-trans retinoic acid. Their secondary palates were excised for analysis. Cytosine extension assay and restriction landmark genomic scanning were performed to analyze DNA methylation status. The expression levels of the DNA methyltransferases were examined by real-time reverse transcriptase–polymerase chain reaction. Results: Using cytosine extension assay, on gestation day 14.5, the status of DNA methylation within CpG islands and in global DNA was decreased significantly in all-trans retinoic acid–treated groups compared with the controls (p < .01 and p < .05). In the controls, the status within CpG islands on gestation day 14.5 was significantly increased compared with gestation days 13.5 and 18.5 (p < .01). Using real-time reverse transcriptase–polymerase chain reaction, there was no significant change in the expression of DNA methyltransferases, except on gestation day 18.5. Using restriction landmark genomic scanning on gestation day 18.5, five spots (0.49%) in the controls and one spot (0.1%) in all-trans retinoic acid–treated groups were specifically detected. Conclusions: These results indicate that changes in DNA methylation may play an important role in the manifestation of cleft palate only caused by environmental factors such as maternal exposure to all-trans retinoic acid.


2017 ◽  
Author(s):  
A Prawan ◽  
S Butsri ◽  
V Kukongviriyapan ◽  
L Senggunprai ◽  
S Kongpetch

Sign in / Sign up

Export Citation Format

Share Document